Updated Wednesday, May 20, 2020
We wanted to further update you on encouraging changes at Fertility Centers of Illinois. The physicians are incredibly excited to resume all treatments including IUI, IVF, egg freezing, donor egg IVF, gestational carrier cycles, and frozen embryo transfer for patients! Due to safety reasons, some patients with serious underlying medical conditions at higher risk for severe illness from COVID-19 may not be allowed to pursue treatment at this time.
Even though treatment is available, we appreciate there are many factors that determine if a patient desires to pursue treatment at this time. We strongly encourage all patients to contact your health care team to schedule a Zoom consultation with your physician to address likely questions this will raise for you, and/or your partner (if applicable), as you decide how to best proceed. Please note insurance companies may not expedite approval in certain cases which may lead to a delay. As always, we appreciate your patience and understanding.
Embryo Options Update
Embryo Options is now offering DocuSign with ID Verification to complete discard forms! This new feature offers patients another avenue to complete discard forms remotely without having to find a notary or coming to our offices. The DocuSign fee is $15. This service only applies to patients discarding all specimens; not partial. In order to prove to identify, patients will need to have an active government-issued ID.
Patients still have the option of finding a notary or have a FCI staff witness when in the office.
Patients can access this service by going to the Embryo Options website and accessing their account.
At Fertility Centers of Illinois, the health and safety of our patients, community, and staff is our priority. Due to the COVID-19 “shelter-in-place” order, we are pleased to offer patients FerTel eHealth appointments. Whether you are wishing to speak to a fertility specialist for the first time or are an existing patient, FerTel eHealth is a great way to connect with our team while protecting yourself from the risk of transmission.
FCI uses the services of Zoom Healthcare to facilitate our video chat appointments. Appointments are available Monday-Friday with weekend appointment times available. Upon completion of your initial FerTel eHealth consultation, patients wishing to move forward will be able to schedule the necessary diagnostic testing appointment to prepare for fertility treatment.
Currently, there is no set standard for insurance providers regarding FerTel eHealth. However, in the midst of this pandemic, many providers are offering coverage and we encourage you to contact your provider for their coverage policy.
Diagnostic Testing Appointments
Diagnostic services are currently available at our consolidated locations. These locations with core staff and scheduled doctors to match patient care volumes offer blood work, semen analysis, transvaginal ultrasound, and saline ultrasound testing.
We believe, like many other medical practices, that this type of testing can be done while continuing to follow all guidelines on social distancing, and will allow our patients to be optimally prepared once treatment cycles are able to resume.
Infertility Treatment Cycles
Under careful consideration, the physician team at FCI has decided to resume fertility treatment cycles on a limited basis. We have been and will continue urgent infertility treatment for oncology patients. We are expanding IVF and egg freezing treatment to include emergent need cases. This is defined as:
- Women using their own eggs who are 40 years of age and older, OR
- Women with diminished ovarian reserve defined as an AMH < 0.7
- All IVF cycles that are initiated will be encouraged to freeze all embryos, without a fresh embryo transfer. This is to allow for the time-sensitive component of IVF to occur, creation of eggs or embryos while continuing to provide a limited delay for the less time-sensitive components of fertility treatment.
We believe ALL fertility treatment is important and arguably essential, but in the context of the COVID-19 crisis, we believe it is imperative to initially limit treatment to emergent care. This will allow us to continue to minimize exposure risks to our patients, staff, and providers. We will continue to expand infertility treatment cycles safely over the coming weeks and months.